Meta Biomed Co., Ltd. (KOSDAQ: 059210)
South Korea
· Delayed Price · Currency is KRW 3,975.00
+60.00 (1.53%)
Oct 14, 2024, 3:19 PM KST
Meta Biomed Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Other Revenue | -0 | -0 | -0 | -0 | - | - | Upgrade
|
| Revenue | 90,091 | 83,101 | 68,942 | 58,780 | 44,998 | 59,391 | Upgrade
|
| Revenue Growth (YoY) | 15.88% | 20.54% | 17.29% | 30.63% | -24.24% | 12.94% | Upgrade
|
| Cost of Revenue | 48,426 | 45,110 | 39,746 | 33,778 | 25,389 | 33,256 | Upgrade
|
| Gross Profit | 41,665 | 37,990 | 29,196 | 25,003 | 19,608 | 26,136 | Upgrade
|
| Selling, General & Admin | 22,923 | 21,651 | 18,682 | 15,455 | 13,359 | 16,224 | Upgrade
|
| Research & Development | 5,314 | 4,538 | 4,343 | 3,339 | 2,227 | 2,453 | Upgrade
|
| Operating Expenses | 29,315 | 27,388 | 23,831 | 19,741 | 17,094 | 20,383 | Upgrade
|
| Operating Income | 12,350 | 10,602 | 5,365 | 5,261 | 2,514 | 5,753 | Upgrade
|
| Interest Expense | -2,900 | -2,315 | -1,390 | -1,145 | -1,011 | -1,190 | Upgrade
|
| Interest & Investment Income | 461.18 | 375.03 | 206.78 | 29.82 | 31.36 | 39.92 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 537.62 | 468.69 | 392.13 | Upgrade
|
| Currency Exchange Gain (Loss) | 2,235 | 232.84 | -523.93 | 1,509 | -1,236 | -5.77 | Upgrade
|
| Other Non Operating Income (Expenses) | 622.73 | -861.26 | -734.59 | 1,171 | 433.05 | 1,087 | Upgrade
|
| EBT Excluding Unusual Items | 12,769 | 8,034 | 2,923 | 7,364 | 1,200 | 6,076 | Upgrade
|
| Gain (Loss) on Sale of Investments | 928.88 | 773.17 | 426.74 | -39.83 | -335.36 | -134.9 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.22 | 12.62 | 47.62 | 801.18 | 180.36 | -2.83 | Upgrade
|
| Asset Writedown | -1,015 | -1,015 | -487.37 | -541.23 | -4,661 | -13.81 | Upgrade
|
| Pretax Income | 12,684 | 7,805 | 2,910 | 7,584 | -3,616 | 5,925 | Upgrade
|
| Income Tax Expense | -1,885 | -2,223 | 64.5 | -1,938 | -529.21 | 170.82 | Upgrade
|
| Earnings From Continuing Operations | 14,570 | 10,027 | 2,846 | 9,521 | -3,087 | 5,754 | Upgrade
|
| Earnings From Discontinued Operations | 67.89 | -211.99 | 754.18 | 140.51 | -1,003 | -2,181 | Upgrade
|
| Net Income to Company | 14,637 | 9,815 | 3,600 | 9,662 | -4,090 | 3,573 | Upgrade
|
| Minority Interest in Earnings | 164.22 | 265 | -972.22 | -140.45 | -3.75 | -226.66 | Upgrade
|
| Net Income | 14,802 | 10,080 | 2,628 | 9,522 | -4,093 | 3,346 | Upgrade
|
| Net Income to Common | 14,802 | 10,080 | 2,628 | 9,522 | -4,093 | 3,346 | Upgrade
|
| Net Income Growth | 298.45% | 283.61% | -72.40% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 6.71% | -0.06% | -0.07% | -0.61% | -1.08% | -0.68% | Upgrade
|
| EPS (Basic) | 647.19 | 440.75 | 114.82 | 415.77 | -177.66 | 143.66 | Upgrade
|
| EPS (Diluted) | 551.65 | 440.75 | 114.82 | 415.77 | -177.66 | 143.36 | Upgrade
|
| EPS Growth | 239.72% | 283.85% | -72.38% | - | - | - | Upgrade
|
| Free Cash Flow | 5,975 | -1,271 | -6,236 | 9,069 | 2,634 | -4,696 | Upgrade
|
| Free Cash Flow Per Share | 244.78 | -55.59 | -272.48 | 396.00 | 114.32 | -201.62 | Upgrade
|
| Dividend Per Share | 20.000 | 20.000 | 20.000 | 20.000 | 10.000 | 10.000 | Upgrade
|
| Dividend Growth | 0% | 0% | 0% | 100.00% | 0% | 0% | Upgrade
|
| Gross Margin | 46.25% | 45.72% | 42.35% | 42.54% | 43.58% | 44.01% | Upgrade
|
| Operating Margin | 13.71% | 12.76% | 7.78% | 8.95% | 5.59% | 9.69% | Upgrade
|
| Profit Margin | 16.43% | 12.13% | 3.81% | 16.20% | -9.10% | 5.63% | Upgrade
|
| Free Cash Flow Margin | 6.63% | -1.53% | -9.04% | 15.43% | 5.85% | -7.91% | Upgrade
|
| EBITDA | 16,937 | 14,825 | 9,225 | 8,832 | 6,455 | 9,466 | Upgrade
|
| EBITDA Margin | 18.80% | 17.84% | 13.38% | 15.03% | 14.35% | 15.94% | Upgrade
|
| D&A For EBITDA | 4,587 | 4,223 | 3,860 | 3,571 | 3,941 | 3,713 | Upgrade
|
| EBIT | 12,350 | 10,602 | 5,365 | 5,261 | 2,514 | 5,753 | Upgrade
|
| EBIT Margin | 13.71% | 12.76% | 7.78% | 8.95% | 5.59% | 9.69% | Upgrade
|
| Effective Tax Rate | - | - | 2.22% | - | - | 2.88% | Upgrade
|
| Advertising Expenses | - | 151.08 | 230.86 | 245.85 | 141.51 | 197.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.